Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes – Endocrinology Advisor

Posted: June 11, 2017 at 6:46 pm


Endocrinology Advisor
Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes
Endocrinology Advisor
Hypogonadal men with type 2 diabetes (T2D) who were treated with testosterone undecanoate (TU) injections demonstrated reductions in glycated hemoglobin A1c (HbA1c) and anthropometric measures, according to data presented at the 77th American ...

and more »

Continue reading here:
Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes - Endocrinology Advisor

Related Post

Comments are closed.

Archives